Quantifying relative within-host replication fitness in influenza virus competition experiments

Journal of Theoretical Biology

Volumn 382, Issue , 2015, Pages 259-271

  Petrie, Stephen M ^a,b   Butler, Jeff ^c   Barr, Ian G ^c,d   McVernon, Jodie ^a,e   Hurt, Aeron C ^c,d   McCaw, James M ^a,e,f  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^c PETER DOHERTY INSTITUTE FOR INFECTION AND IMMUNITY   (Australia)

^d UNIVERSITY OF BALLARAT   (Australia)

^e ROYAL CHILDREN'S HOSPITAL   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Drug resistance; Influenza; Mathematical model; Pathogen fitness; Viral kinetics

Indexed keywords

OSELTAMIVIR; VIRUS SIALIDASE; SIALIDASE;

DRUG RESISTANCE; FITNESS; GENE; HOST; INFLUENZA; NUMERICAL MODEL; PATHOGEN; VIRUS;

ANTIVIRAL RESISTANCE; ARTICLE; CONTROLLED STUDY; DYNAMICS; EPITHELIUM CELL; FERRET; HYPOTHESIS; INFLUENZA VIRUS A H1N1; MATHEMATICAL ANALYSIS; MIXED INFECTION; NEURAMINIDASE GENE; NONHUMAN; PRIORITY JOURNAL; REPRODUCTIVE FITNESS; STRAIN DIFFERENCE; VIRAL PHENOMENA AND FUNCTIONS; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS MUTATION; VIRUS REPLICATION; VIRUS STRAIN; WITHIN HOST REPLICATION FITNESS; AMINO ACID SUBSTITUTION; BIOLOGICAL MODEL; EPIDEMIC; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; INFLUENZA A VIRUS (H1N1); INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MUTATION; PHYSIOLOGY; VIROLOGY;

AUSTRALIA;

ORTHOMYXOVIRIDAE;

AMINO ACID SUBSTITUTION; DISEASE OUTBREAKS; GENES, VIRAL; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MODELS, BIOLOGICAL; MUTATION; NEURAMINIDASE; VIRUS REPLICATION;

EID: 84938092285     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2015.07.003     Document Type: Article

References (63)

1. Arndt U., Wennemuth G., Barth P., Nain M., Al-Abed Y., Meinhardt A., Gemsa D., Bacher M. Release of macrophage migration inhibitory factor and CXCL8/interleukin-8 from lung epithelial cells rendered necrotic by influenza A virus infection. J. Virol. 2002, 76(18):9298. URL: http://jvi.asm.org/cgi/content/abstract/76/18/9298. 10.1128/JVI.76.18.9298.
2. Baccam P., Beauchemin C.A.A., Macken C.A., Hayden F.G., Perelson A.S. Kinetics of influenza A virus infection in humans. J. Virol. 2006, 80(15):7590-7599. URL: http://www.ncbi.nlm.nih.gov/pubmed/16840338. 10.1128/JVI.01623-05.
3. Beauchemin C.A.A., Handel A. A review of mathematical models of influenza A infections within a host or cell culture. lessons learned and challenges ahead. BMC Pub. Health 2011, 11(Suppl 1):S7. URL: http://www.ncbi.nlm.nih.gov/pubmed/21356136. 10.1186/1471-2458-11-S1-S7.
4. Beauchemin C.A.A., McSharry J.J., Drusano G.L., Nguyen J.T., Went G.T., Ribeiro R.M., Perelson A.S. Modeling amantadine treatment of influenza a virus in vitro. J. Theor. Biol. 2008, 254(2):439-451. URL: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2663526&tool=pmcentrez&rendertype=abstract. 10.1016/j.jtbi.2008.05.031.
5. Burnham K.P., Anderson D.R. Multimodel inference. understanding aic and bic in model selection. Sociol. Methods Res. 2004, 33(2):261-304. URL: http://smr.sagepub.com/cgi/doi/10.1177/0049124104268644. 10.1177/0049124104268644.
6. Butler J., Hooper K.A., Petrie S., Lee R., Maurer-Stroh S., Reh L., Guarnaccia T., Baas C., Xue L., Vitesnik S., Leang S.-K., McVernon J., Kelso A., Barr I.G., McCaw J.M., Bloom J.D., Hurt A.C. Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses. PLoS Pathog. 2014, 10(4):e1004065. URL: http://dx.plos.org/10.1371/journal.ppat.1004065. 10.1371/journal.ppat.1004065.
7. Centers for Disease Control and Prevention (CDC), 2008. Update: Influenza activity-United States, September 30, 2007-April 5, 2008, and composition of the 2008-09 influenza vaccine, MMWR. Morb. Mortal. Wkl. Rep. 57 (15) 404-409.
8. Centers for Disease Control and Prevention (CDC), 2009. Update: influenza activity-United States, September 28, 2008-April 4, 2009, and composition of the 2009-10 influenza vaccine, MMWR Morb. Mortal. Wkl. Rep. 58 (14) 369-374. URL:. http://www.ncbi.nlm.nih.gov/pubmed/21918493.
9. Colman P.M. Influenza virus neuraminidase. structure, antibodies, and inhibitors. Protein Sci. 1994, 3(10):1687-1696. URL: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2142611&tool=pmcentrez&rendertype=abstract. 10.1002/pro.5560031007.
10. de Vries E., de Vries R.P., Wienholts M.J., Floris C.E., Jacobs M.-S., van den Heuvel A., Rottier P.J.M., de Haan C.a.M. Influenza a virus entry into cells lacking sialylated N-glycans. Proc. Natl. Acad. Sci. U.S.A. 2012, 109(19):7457-7462. URL: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3358892&tool=pmcentrez&rendertype=abstract. 10.1073/pnas.1200987109.
11. Dharan N.J., Gubareva L.V., Meyer J.J., Okomo-Adhiambo M., McClinton R.C., Marshall S.A., George K., Epperson S., Brammer L., Klimov A.I., Bresee J.S., Fry A.M. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. J. Am. Med. Assoc. 2009, 301(10):1034-1041. URL: http://www.ncbi.nlm.nih.gov/pubmed/21737049. 10.1001/jama.2009.294.
12. Dobrovolny H.M., Reddy M.B., Kamal M.A., Rayner C.R., Beauchemin C.A.A. Assessing mathematical models of influenza infections using features of the immune response. PLoS ONE 2013, 8(2):e57088. 10.1371/journal.pone.0057088.
13. Donaldson J., Schnabel R. Computational experience with confidence regions and confidence intervals for nonlinear least squares. Technometrics 1987, 29(1):67-82. URL: http://www.jstor.org/stable/10.2307/1269884.
14. Gaur P., Ranjan P., Sharma S., Patel J.R., Bowzard J.B., Rahman S.K., Kumari R., Gangappa S., Katz J.M., Cox N.J., Lal R.B., Sambhara S., Lal S.K. Influenza A virus neuraminidase protein enhances cell survival through interaction with carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) protein. J. Biol. Chem. 2012, 287(18):15109-15117. URL: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3340274&tool=pmcentrez&rendertype=abstract. 10.1074/jbc.M111.328070.
15. Gaush C.R., Smith T.F. Replication and plaque assay of influenza virus in an established line of canine kidney cells. Appl. Microbiol. 1968, 16(4):588-594. URL: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=547475&tool=pmcentrez&rendertype=abstract.
16. Gerlach T., Kühling L., Uhlendorff J., Laukemper V., Matrosovich T., Czudai-Matwich V., Schwalm F., Klenk H.-D., Matrosovich M. Characterization of the neuraminidase of the H1N1/09 pandemic influenza virus. Vaccine 2012, 30(51):7348-7352. URL: http://www.ncbi.nlm.nih.gov/pubmed/23063828. 10.1016/j.vaccine.2012.09.078.
17. Gong J., Xu W., Zhang J. Structure and functions of influenza virus neuraminidase. Curr. Med. Chem. 2007, 14(1):113-122. URL: http://www.ncbi.nlm.nih.gov/pubmed/17266572.
18. Grienke U., Schmidtke M., von Grafenstein S., Kirchmair J., Liedl K.R., Rollinger J.M. Influenza neuraminidase. a druggable target for natural products. Nat. Prod. Rep. 2012, 29(1):11-36. URL: http://www.ncbi.nlm.nih.gov/pubmed/22025274. 10.1039/c1np00053e.
19. Gubareva L.V., Kaiser L., Hayden F.G. Influenza virus neuraminidase inhibitors. The Lancet 2000, 355:827-835. URL: http://www.sciencedirect.com/science/article/pii/S0140673699114338.
20. Handel A., Longini I.M., Antia R. Neuraminidase inhibitor resistance in influenza. assessing the danger of its generation and spread. PLoS Comput. Biol. 2007, 3(12):e240. URL: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2134965&tool=pmcentrez&rendertype=abstract. 10.1371/journal.pcbi.0030240.
21. Hattrup C.L., Gendler S.J. Structure and function of the cell surface (tethered) mucins. Annu. Rev. Physiol. 2008, 70:431-457. URL: http://www.ncbi.nlm.nih.gov/pubmed/17850209. 10.1146/annurev.physiol.70.113006.100659.
22. Hauge S.H., Dudman S., Borgen K., Lackenby A., Hungnes O. Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerg. Infect. Dis. 2009, 15(2):155-162. URL: http://www.cdc.gov/eid/content/15/2/155.htm. 10.3201/eid1502.081031.
23. Holder B.P., Beauchemin C.A.A. Exploring the effect of biological delays in kinetic models of influenza within a host or cell culture. BMC Publ. Health 2011, 11(Suppl 1):S10. URL: http://www.ncbi.nlm.nih.gov/pubmed/21356129. 10.1186/1471-2458-11-S1-S10.
24. Holder B.P., Simon P., Liao L.E., Abed Y., Bouhy X., Beauchemin C.A.A., Boivin G. Assessing the in vitro fitness of an oseltamivir-resistant seasonal A/H1N1 influenza strain using a mathematical model. PloS ONE 2011, 6(3):e14767. URL: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3063785&tool=pmcentrez&rendertype=abstract. 10.1371/journal.pone.0014767.
25. Horsfall F.L. On the reproduction of influenza virus. Quantitative studies with procedures which enumerate infective and hemagglutinating virus particles. J. Exp. Med. 1954, 100(2):135-161. URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2136364.
26. Huang I.-C., Li W., Sui J., Marasco W., Choe H., Farzan M. Influenza a virus neuraminidase limits viral superinfection. J. Virol. 2008, 82(10):4834-4843. URL: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2346733&tool=pmcentrez&rendertype=abstract. 10.1128/JVI.00079-08.
27. Hurt, A.C., Ernest, J., Deng, Y.-M., Iannello, P., Besselaar, T.G., Birch, C., Buchy, P., Chittaganpitch, M., Chiu, S.-C., Dwyer, D., Guigon, A., Harrower, B., Kei, I.P., Kok, T., Lin, C., McPhie, K., Mohd, A., Olveda, R., Panayotou, T., Rawlinson, W., Scott, L., Smith, D., D[U+05F3]Souza, H., Komadina, N., Shaw, R., Kelso, A., Barr, I.G., 2009. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania South East Asia and South Africa. Antivir. Res. 83 (1), 90-93.. http://www.ncbi.nlm.nih.gov/pubmed/19501261.
28. Hurt A.C., Nor'e S.S., McCaw J.M., Fryer H.R., Mosse J., McLean A.R., Barr I.G. Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model. J. Virol. 2010, 84(18):9427-9438. URL: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2937593&tool=pmcentrez&rendertype=abstract. 10.1128/JVI.00373-10.
29. Kelso A., Hurt A.C. Drug-resistant influenza viruses. why fitness matters. Nat. Med. 2012, 18(10):1470-1472.
30. Lai J.C.C., Chan W.W.L., Kien F., Nicholls J.M., Peiris J.S.M., Garcia J.-M. Formation of virus-like particles from human cell lines exclusively expressing influenza neuraminidase. J. Gen. Virol. 2010, 91(Pt 9):2322-2330. URL: http://www.ncbi.nlm.nih.gov/pubmed/20505010. 10.1099/vir.0.019935-0.
31. Möhler L., Flockerzi D., Sann H., Reichl U. Mathematical model of influenza a virus production in large-scale microcarrier culture. Biotechnol. Bioeng. 2005, 90(1):46-58. http://www.ncbi.nlm.nih.gov/pubmed/15736163. 10.1002/bit.20363.
32. Marée A.F.M., Keulen W., Boucher C.A.B., de Boer R.J. Estimating relative fitness in viral competition experiments. J. Virol. 2000, 74(23):11067-11072. URL: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=113186&tool=pmcentrez&rendertype=abstract.
33. Matrosovich M.N., Matrosovich T.Y., Gray T., Roberts N.A., Klenk H.-D. Neuraminidase is Important for the initiation of influenza virus infection in human airway epithelium. J. Virol. 2004, 78(22):12665-12667. 10.1128/JVI.78.22.12665.
34. Meijer A., Lackenby A., Hungnes O., Lina B., van der Werf S., Schweiger B., Opp M., Paget J., van der Kassteele J., Hay A., Zambon M. Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Emerg. Infect. Dis. 2009, 15(4):552-560. URL: http://www.cdc.gov/eid/content/15/4/552.htm. 10.3201/eid1504.081280.
35. Miao H., Hollenbaugh J.A., Zand M.S., Holden-Wiltse J., Mosmann T.R., Perelson A.S., Wu H., Topham D.J. Quantifying the early immune response and adaptive immune response kinetics in mice infected with influenza a virus. J. Virol. 2010, 84(13):6687-6698. URL: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2903284&tool=pmcentrez&rendertype=abstract. 10.1128/JVI.00266-10.
36. Morris S.J., Price G.E., Barnett J.M., Hiscox S.A., Smith H., Sweet C. Role of neuraminidase in influenza virus-induced apoptosis. J. Gener. Virol. 1999, 80(1):137-146. URL http://vir.sgmjournals.org/content/80/1/137.short.
37. Moscona A. Global transmission of oseltamivir-resistant influenza. New Engl. J. Med. 2009, 360(10):953-956. URL: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3089626&tool=pmcentrez&rendertype=abstract. 10.1056/NEJMp0900648.
38. Nayak D.P., Hui E.K.-W., Barman S. Assembly and budding of influenza virus. Virus Res. 2004, 106(2):147-165. URL: http://www.ncbi.nlm.nih.gov/pubmed/15567494. 10.1016/j.virusres.2004.08.012.
39. Nicholson K.G., Wood J.M., Zambon M. Influenza. Lancet 2003, 362(9397):1733-1745. URL: http://www.ncbi.nlm.nih.gov/pubmed/19799843. 10.1016/S0140-6736(03)14854-4.
40. Nishikawa T., Shimizu K., Tanaka T., Kuroda K., Takayama T., Yamamoto T., Hanada N., Hamada Y. Bacterial neuraminidase rescues influenza virus replication from inhibition by a neuraminidase inhibitor. PloS ONE 2012, 7(9):e45371. URL: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3445474&tool=pmcentrez&rendertype=abstract. 10.1371/journal.pone.0045371.
41. Orthel F.W. Influenza virus titrations and the inhibitor of hemagglutination in normal allantoic fluid. Archiv für die gesamte Virusforschung 1972, 38(4):347-356. URL: http://www.ncbi.nlm.nih.gov/pubmed/5083408.
42. Paucker K., Henle W. Studies on host-virus interactions in the chick embryo-influenza virus system. XI. The effect of partial inactivation of standard seed virus at 37C upon the progeny. J. Exp. Med. 1955, 101(5):479-492. URL: http://jem.rupress.org/content/90/1/23.abstract.
43. Pawelek K.A., Huynh G.T., Quinlivan M., Cullinane A., Rong L., Perelson A.S. Modeling within-host dynamics of influenza virus infection including immune responses. PLoS Comput. Biol. 2012, 8(6):e1002588. URL: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3386161&tool=pmcentrez&rendertype=abstract. 10.1371/journal.pcbi.1002588.
44. Petrie S.M., Guarnaccia T., Laurie K.L., Hurt A.C., McVernon J., McCaw J.M. Reducing uncertainty in within-host parameter estimates of influenza infection by measuring both infectious and total viral load. PloS ONE 2013, 8(5):e64098. URL: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3655064&tool=pmcentrez&rendertype=abstract. 10.1371/journal.pone.0064098.
45. Pinilla L.T., Holder B.P., Abed Y., Boivin G., Beauchemin C.A.A. The H275Y neuraminidase mutation of the pandemic A/H1N1 influenza virus lengthens the eclipse phase and reduces viral output of infected cells, potentially compromising fitness in ferrets. J. Virol. 2012, 86(19):10651-10660. URL: http://www.ncbi.nlm.nih.gov/pubmed/22837199. 10.1128/JVI.07244-11.
46. Rossman J.S., Lamb R.a. Influenza virus assembly and budding. Virology 2011, 411(2):229-236. URL: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3086653&tool=pmcentrez&rendertype=abstract. 10.1016/j.virol.2010.12.003.
47. Saenz R.A., Quinlivan M., Elton D., Macrae S., Blunden A.S., Mumford J.A., Daly J.M., Digard P., Cullinane A., Grenfell B.T., McCauley J.W., Wood J.L.N., Gog J.R. Dynamics of influenza virus infection and pathology. J. Virol. 2010, 84(8):3974-3983. URL: http://www.ncbi.nlm.nih.gov/pubmed/20130053. 10.1128/JVI.02078-09.
48. Schulze-Horsel J., Schulze M., Agalaridis G., Genzel Y., Reichl U. Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production-flow cytometry and mathematical modeling. Vaccine 2009, 27(20):2712-2722. URL: http://www.ncbi.nlm.nih.gov/pubmed/19428884. 10.1016/j.vaccine.2009.02.027.
49. Schwaab M., Biscaiajr E., Monteiro J., Pinto J. Nonlinear parameter estimation through particle swarm optimization. Chem. Eng. Sci. 2008, 63(6):1542-1552. URL: http://linkinghub.elsevier.com/retrieve/pii/S0009250907008755. 10.1016/j.ces.2007.11.024.
50. Sheu T.G., Deyde V.M., Okomo-Adhiambo M., Garten R.J., Xu X., Bright R.a., Butler E.N., Wallis T.R., Klimov A.I., Gubareva L.V. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob. Agents Chemother. 2008, 52(9):3284-3292. URL: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2533500&tool=pmcentrez&rendertype=abstract. 10.1128/AAC.00555-08.
51. Smith A.M., Perelson A.S. Influenza A virus infection kinetics. quantitative data and models. Wiley Interdiscip. Rev.: Syst. Biol. Med. 2011, 3(4):429-445. URL: http://onlinelibrary.wiley.com/doi/10.1002/wsbm.129/abstract. 10.1002/wsbm.129.
52. Smith A.M., Adler F.R., McAuley J.L., Gutenkunst R.N., Ribeiro R.M., McCullers J.A., Perelson A.S. Effect of 1918 PB1-F2 expression on influenza a virus infection kinetics. PLoS Comput. Biol. 2011, 7(2):e1001081. URL: http://dx.plos.org/10.1371/journal.pcbi.1001081. 10.1371/journal.pcbi.1001081.
53. Su B., Wurtzer S., Rameix-Welti M.-A., Dwyer D.E., van der Werf S., Naffakh N., Clavel F., Labrosse B. Enhancement of the influenza A hemagglutinin (HA)-mediated cell-cell fusion and virus entry by the viral neuraminidase (NA). PloS ONE 2009, 4(12):e8495. URL: http://www.ncbi.nlm.nih.gov/pubmed/20041119. 10.1371/journal.pone.0008495.
54. Sullivan S.J., Jacobson R.M., Dowdle W.R., Poland G.A. 2009 H1N1 influenza. Mayo Clin. Proc., Mayo Clin. 2010, 85(1):64-76. URL: http://www.ncbi.nlm.nih.gov/pubmed/20007905. 10.4065/mcp.2009.0588.
55. Suzuki T., Takahashi T., Guo C.-T., Hidari K.I.-P.J., Miyamoto D., Goto H., Kawaoka Y., Suzuki Y. Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication. J. Virol. 2005, 79(18):11705-11715. URL: http://jvi.asm.org/content/79/18/11705.short. 10.1128/JVI.79.18.11705.
56. Thornton D.J., Rousseau K., McGuckin M.A. Structure and function of the polymeric mucins in airways mucus. Annu. Rev. Physiol. 2008, 70:459-486. URL: http://www.ncbi.nlm.nih.gov/pubmed/17850213. 10.1146/annurev.physiol.70.113006.100702.
57. Ushirogawa H., Ohuchi M. Novel antiviral activity of neuraminidase inhibitors against an avian influenza A virus. Virol. J. 2011, 8:411. URL: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3170304&tool=pmcentrez&rendertype=abstract. 10.1186/1743-422X-8-411.
58. Wagner R., Matrosovich M., Klenk H.-D. Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev. Med. Virol. 2002, 12(3):159-166. URL: http://www.ncbi.nlm.nih.gov/pubmed/11987141. 10.1002/rmv.352.
59. Wong D.D.Y., Choy K.-T., Chan R.W.Y., Sia S.F., Chiu H.-P., Cheung P.P.H., Chan M.C.W., Peiris J.S.M., Yen H.-L. Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation. J. Virol. 2012, 86(19):10558-10570. URL: http://www.ncbi.nlm.nih.gov/pubmed/22811535. 10.1128/JVI.00985-12.
60. Wu H., Huang Y., Dykes C., Liu D., Ma J., Perelson A.S., Demeter L.M. Modeling and estimation of replication fitness of human immunodeficiency virus type 1 in vitro experiments by using a growth competition assay. J. Virol. 2006, 80(5):2380-2389. URL: http://jvi.asm.org/cgi/content/abstract/80/5/2380. 10.1128/JVI.80.5.2380.
61. Yondola M.a., Fernandes F., Belicha-Villanueva A., Uccelini M., Gao Q., Carter C., Palese P. Budding capability of the influenza virus neuraminidase can be modulated by tetherin. J. Virol. 2011, 85(6):2480-2491. URL: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3067929&tool=pmcentrez&rendertype=abstract. 10.1128/JVI.02188-10.
62. Zhirnov O., Klenk H.-D. Human influenza A viruses are proteolytically activated and do not induce apoptosis in CACO-2 cells. Virology 2003, 313(1):198-212. URL: http://linkinghub.elsevier.com/retrieve/pii/S0042682203002642. 10.1016/S0042-6822(03)00264-2.
63. Zhu X., McBride R., Nycholat C.M., Yu W., Paulson J.C., Wilson I.a. Influenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic acid receptors. J. Virol. 2012, 86(24):13371-13383. URL: http://www.ncbi.nlm.nih.gov/pubmed/23015718. 10.1128/JVI.01426-12.